Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fdaec2667305bd08be7cdb7f1049234 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0075 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L5-00 |
filingDate |
2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9be07bdba25a10eb0025ed2081a4bff3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d49ae2d2b7eb57a6944ec13e0300889b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dd8420b5a37caea584586009668fb83 |
publicationDate |
2020-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020332088-A1 |
titleOfInvention |
Cellular glycosaminoglycan compositions and methods of making and using |
abstract |
Disclosed herein are substantially pure glycosaminoglycan compositions derived from genetically modified cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021050634-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110520532-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102020007691-A1 |
priorityDate |
2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |